Back to
MORGAN STANLEY
TORCNShowing 6 of 7 quarters
Position history for
MORGAN STANLEY's holdings in ADICET BIO INC
As of its Q3 2025 13F, Morgan Stanley held 73,682 shares of TORCN (Adicet Bio), worth $59,697. Morgan Stanley's 13F filings listed TORCN from Q2 2024 to Q3 2025, 6 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$387,229
Total Shares Change
-268,909
Quarter-by-Quarter History
Other major holders of TORCN: RTW INVESTMENTS, LP